Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Voyager Therapeutics, Inc. - Common Stock
(NQ:
VYGR
)
4.455
-0.415 (-8.52%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Voyager Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
September 30, 2025
Via
Benzinga
Voyager Therapeutics Alzheimer's Portfolio And ALPL NeuroShuttle Underscore Platform Momentum: Analyst
↗
September 15, 2025
Voyager's Alzheimer's programs show longer CNS exposure and potential gene therapy advances, with analysts maintaining a Buy rating and $30 price target.
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
May 09, 2025
Via
Benzinga
7 Analysts Assess Voyager Therapeutics: What You Need To Know
↗
April 08, 2025
Via
Benzinga
Bragar Eagel & Squire, P.C. Is Investigating Dave, Red Cat, Perpetua, and Voyager and Encourages Investors to Contact the Firm
March 20, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
A Glimpse Into The Expert Outlook On Voyager Therapeutics Through 5 Analysts
↗
December 02, 2024
Via
Benzinga
A Glimpse Into The Expert Outlook On Voyager Therapeutics Through 4 Analysts
↗
March 12, 2025
Via
Benzinga
Earnings Scheduled For March 11, 2025
↗
March 11, 2025
Via
Benzinga
Voyager Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
↗
November 14, 2024
Via
Benzinga
Earnings Scheduled For November 12, 2024
↗
November 12, 2024
Via
Benzinga
Preview: Voyager Therapeutics's Earnings
↗
November 11, 2024
Via
Benzinga
In-Depth Examination Of 4 Analyst Recommendations For Voyager Therapeutics
↗
October 16, 2024
Via
Benzinga
VOYAGER ALERT: Bragar Eagel & Squire, P.C. is Investigating Voyager Therapeutics, Inc. on Behalf of Voyager Stockholders and Encourages Investors to Contact the Firm
February 24, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
VYGR Investors Have Opportunity to Join Voyager Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
February 20, 2025
From
The Schall Law Firm
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
October 22, 2024
Via
Benzinga
What Analysts Are Saying About Voyager Therapeutics Stock
↗
July 31, 2024
Via
Benzinga
Is VOYAGER THERAPEUTICS INC (NASDAQ:VYGR) suited for growth investing?
↗
April 17, 2024
Should you consider VOYAGER THERAPEUTICS INC (NASDAQ:VYGR) for growth investing?
Via
Chartmill
Is NASDAQ:VYGR a Fit for Growth Investing Strategies?
↗
March 27, 2024
High growth, ROE and relative strength for VOYAGER THERAPEUTICS INC (NASDAQ:VYGR), growth investors may appreciate this.
Via
Chartmill
Get “Picky” With Stocks For September Profits
↗
September 09, 2024
Via
Talk Markets
3 High-Growth Stocks Poised To Double By Next Year
↗
August 28, 2024
The article outlines three high-growth stocks that could double by 2025, using specific screening criteria: strong buy ratings from multiple analysts, significant revenue and earnings growth, and...
Via
Talk Markets
7 Biotech Stocks to Buy for Their Game-Changing Potential
↗
August 08, 2024
Although the market may be reeling from the recent fallout, the red ink presents a viable opportunity in these biotech stocks.
Via
InvestorPlace
VYGR Stock Earnings: Voyager Therapeutics Beats EPS, Beats Revenue for Q2 2024
↗
August 06, 2024
VYGR stock results show that Voyager Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
VYGR Stock Earnings: Voyager Therapeutics Beats EPS, Beats Revenue for Q1 2024
↗
May 13, 2024
VYGR stock results show that Voyager Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
The Healthcare Bargain Blitz: 7 Undervalued Stocks to Inject into Your Portfolio
↗
March 27, 2024
With a possible rotation away from the technology space, these are the undervalued healthcare stocks to consider.
Via
InvestorPlace
Delving into NASDAQ:VYGR's Growth Prospects.
↗
March 26, 2024
Why VOYAGER THERAPEUTICS INC (NASDAQ:VYGR) qualifies as a high growth stock.
Via
Chartmill
Exploring NASDAQ:VYGR's growth characteristics.
↗
March 05, 2024
VOYAGER THERAPEUTICS INC (NASDAQ:VYGR) may be suited for growth investing, we'll explore why in this article.
Via
Chartmill
Cheap Thrills: 7 Promising Value Stocks You Can Buy for Under $20
↗
March 21, 2024
With so many thousands of securities available, there are bound to be compelling ideas for value stocks under $20.
Via
InvestorPlace
Analyst Bullish On Gene Therapy-Focused Voyager Therapeutics Sees Best In Class Potential For Its Neurogenetic Medicine Platform
↗
March 19, 2024
Unlock potential with Voyager Therapeutics as HC Wainwright initiates coverage highlights its TRACER capsid platform, promising CNS-targeted gene therapies and strategic partnerships driving long-term...
Via
Benzinga
Is VOYAGER THERAPEUTICS INC (NASDAQ:VYGR) suited for growth investing?
↗
March 05, 2024
Unlocking the Growth Potential of VOYAGER THERAPEUTICS INC (NASDAQ:VYGR).
Via
Chartmill
Tech Stocks Set To Rise Thursday As January Inflation Data Fails To Scare Markets, Small Caps Surge
↗
February 29, 2024
Tech stocks drive pre-market surge, Fed inflation data fails to disrupt rate cut expectations. Futures up for Nasdaq, S&P 500, and small caps.
Via
Benzinga
Topics
Economy
Stocks
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
